CLOs on the Move

Rx Scribe

www.rxscribe.net

 
Rx Scribe is a Savannah, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Beasley WM R Ddsjffry Olsn

Beasley WM R Ddsjffry Olsn is a Baxter, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Grand Rounds

Grand Rounds` vision is to create a path to great health and health care, for everyone, everywhere. Founded in 2011, the company provides an employer-based platform that delivers improved outcomes for patients and their families. It does this through an end-to-end solution that connects patients with care informed by the latest and best practices—preventing and correcting misdiagnoses and unnecessary or failed treatments. Named second among Glassdoor`s 2016 Best Places to Work, Grand Rounds helps restore individual health and quality of life, and offers employers lower health care spend and higher employee productivity

Occupational Therapy Rochester

Occupational Therapy Rochester is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Laser Skin Care Center

Laser Skin Care Center is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fertility Centers of Illinois

Fertility Centers of Illinois is one of the leading fertility treatment practices in the United States, providing advanced reproductive endocrinology services in the Chicago area for more than 30 years. Fertility Centers of Illinois physicians, embryologists and support staff are stringently chosen based on educational background, medical skills and their ability to collaborate. With a team of 11 nationally and internationally recognized reproductive physicians who treat thousands of patients each year, the practice has earned a reputation for overcoming hard-to-solve fertility issues. Fertility Centers of Illinois is dedicated to clinical excellence and continues to invest in the latest technologies and research.